SciELO - Scientific Electronic Library Online

 
vol.22 issue2Non-occupational Asbestosis: a Potential Risk that should be Considered author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista americana de medicina respiratoria

On-line version ISSN 1852-236X

Abstract

PALMERO, Domingo et al. Practical Pharmacological Aspects of Drugs Used for the Treatment of Drug-Resistant Tuberculosis in Adults and Children. Rev. am. med. respir. [online]. 2022, vol.22, n.2, pp.264-270. ISSN 1852-236X.

The emergence of resistant strains of Mycobacterium tuberculosis to multiple drugs and the difficulties of their diagnosis and treatment constitute a challenge to global public health. To face this challenge, new anti-tuberculosis drugs, such as bedaquiline, pretomanid, and delamanid, as well as replacement drugs, such as fluoroquinolones, linezolid and clofazimine, are used. Based on the evidence provided by multicenter studies, drugs associated with a better prognosis of drug-resistant tuberculosis have been discovered and, recently, a new classification has been proposed, as well as new totally oral regimens. In this review, we describe current treatment regimens and practical pharmacological aspects required when prescribing new drug-resistant tuberculosis treatment regimens.

Keywords : Tuberculosis; Drug-resistance; MDR-TB; Pharmacology.

        · abstract in Spanish     · text in English     · English ( pdf )